It has been reported that circ‐SMARCA5 is a tumor suppressor in NSCLC26; hsa_circ_0007385 is a new biomarker for monitoring disease and predicting prognosis in NSCLC patients 27; circRNA_103762 stimulates multidrug resistance in NSCLC via targeting DNA damage‐inducible transcript 3 (CHOP).28 This evidence concerns the gene SMARCA5 and neoplasm.